Subcutaneous Administrationとは 意味・読み方・使い方

The methods comprises biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα).例文帳に追加

ヒト腫瘍壊死因子α（ｈＴＮＦα）に特異的に結合するヒト抗体、好ましくは組換えヒト抗体を隔週皮下投与する。 - 特許庁

To provide an antibody-containing formulation which is stable and suited for subcutaneous administration, wherein dimerization and deamidation are suppressed during long-term storage.例文帳に追加

長期保存時の二量体生成や脱アミド化が抑制された、安定な、皮下投与に適した抗体含有製剤を提供する。 - 特許庁

The methods of treating disorders in which TFNα activity is detrimental includes biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα).例文帳に追加

ヒト腫瘍壊死因子α（ｈＴＮＦα）に特異的に結合するヒト抗体、好ましくは組換えヒト抗体を隔週皮下投与する。 - 特許庁

This prevention or treatment of vascular restenosis depends on intravenous administration (i.v.), intramuscular administration (i.m.), or subcutaneous administration (s.c.) using a bisphosphonate (BP), a pyrophosphate (PP), a complex of BP or PP, a polymer of BP or PP, or their pharmaceutically permissible salts or esters.例文帳に追加

ビスホスホネート（ＢＰ）、ピロリン酸塩（ＰＰ）、ＢＰもしくはＰＰの複合体、ＢＰもしくはＰＰのポリマー、またはそれらの薬学的に許容し得る塩もしくはエステルを用いた、静脈内投与（i.v.）、筋肉内投与（i.m.）、又は皮下投与（s.c.）による、血管再狭窄の予防または治療。 - 特許庁

The method is provided for treating disorders via biweekly subcutaneous administration of human antibodies, preferably recombinant human antibodies, in combination with one or more other drugs which are useful for treating the disorder.例文帳に追加

該抗体、好ましくは組み換え型ヒト抗体を、障害の治療に有用な、一種以上の他の薬剤と組み合わせて隔週で皮下投与することによって治療する方法。 - 特許庁

In the case of administering an antigenic peptide by intracutaneous or subcutaneous administration in the form of an aqueous solution, the antigen is diffused before being recognized by an immunocompetent cell owing to the quick diffusion of the solution, and high immunity induction is unattainable.例文帳に追加

抗原性ペプチドを皮内または皮下投与する場合、水溶液の状態では拡散が早く免疫担当細胞に認識される前に抗原が拡散して、高い免疫誘導が得られない。 - 特許庁

The sustained release follicle-stimulant is obtained by mixing an aluminum hydroxide gel excellent in adsorptivity with follicle-stimulating hormone, and the method of inducing effective superovulation even by single dose administration comprises performing the subcutaneous, intracutaneous or intramuscular administration of the sustained release follicle-stimulant to an experimental animal to impart sustained releasability to the follicle-stimulating hormone administered.例文帳に追加

吸着性に優れた水酸化アルミニウムゲルを卵胞刺激ホルモンと混合することで得られる徐放性卵胞刺激剤を、実験動物の皮下、皮内または筋肉内に投与することで、投与する卵胞刺激ホルモンに徐放性を付与して、単回投与でも有効な過剰排卵を誘起させる方法を提供する。 - 特許庁

The method for inactivating the retrovirus such as the HIV present in blood or a body or other viruses comprises carrying out subcutaneous injection, injection into blood or oral administration of a trace amount of the silicone emulsion prepared by mixing a dimethylsilicone oil compound obtained by formulating a dimethylsilicone oil having a dimethylpolysiloxane structure with a special dispersing agent with the emulsifying agent and emulsifying the dimethylsilicone oil compound into a patient suffering from the viral infection.例文帳に追加

ジメチルポリシロキサン構造を持った、ジメチルシリコーンオイルに特殊な分散剤を配合したジメチルシリコーンオイルコンパウンドに乳化剤を混合して乳化したシリコーンエマルジョンをウイルス感染患者に極く微量、皮下注射、血液中注射、又は経口投与して、血液中又は体内に存在するＨＩＶ等のレトロウイルス、その他のウイルスの不活化方法。 - 特許庁